These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

181 related articles for article (PubMed ID: 16931475)

  • 21. Functional-MRI evaluation of pain processing in chronic migraine with medication overuse.
    Chiapparini L; Grazzi L; Ferraro S; Mandelli ML; Usai S; Andrasik F; Bruzzone MG; Bussone G
    Neurol Sci; 2009 May; 30 Suppl 1():S71-4. PubMed ID: 19415430
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Allodynia-associated symptoms, pain intensity and time to treatment: predicting treatment response in acute migraine intervention.
    Cady RK; Freitag FG; Mathew NT; Elkind AH; Mao L; Fisher AC; Biondi DM; Finlayson G; Greenberg SJ; Hulihan JF
    Headache; 2009 Mar; 49(3):350-63. PubMed ID: 19220503
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Treatment guidelines for acute migraine attacks].
    Treatment Guideline Subcommittee of Taiwan Headache Society
    Acta Neurol Taiwan; 2007 Dec; 16(4):251-68. PubMed ID: 18220021
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Chronic migraine: medication overuse headache.
    Rothrock JF
    Headache; 2007 Mar; 47(3):467-8. PubMed ID: 17371376
    [No Abstract]   [Full Text] [Related]  

  • 25. Short-term outcomes of tension type and migraine headache in children.
    Sri-udomkajorn S; Ruangsuwan S
    J Med Assoc Thai; 2008 Oct; 91 Suppl 3():S104-8. PubMed ID: 19253504
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Intravenous dexamethasone vs placebo as adjunctive therapy to reduce the recurrence rate of acute migraine headaches: a multicenter, double-blinded, placebo-controlled randomized clinical trial.
    Donaldson D; Sundermann R; Jackson R; Bastani A
    Am J Emerg Med; 2008 Feb; 26(2):124-30. PubMed ID: 18272089
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Acute migraine in the Emergency Department: extending European principles of management.
    Martelletti P; Farinelli I; Steiner TJ;
    Intern Emerg Med; 2008 Oct; 3 Suppl 1():S17-24. PubMed ID: 18785015
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Applying the benefits of the AwM study in the clinic.
    Dodick DW
    Cephalalgia; 2008 Sep; 28 Suppl 2():42-9. PubMed ID: 18715332
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Examining the utility of in-clinic "rescue" therapy for acute migraine.
    Morey V; Rothrock JF
    Headache; 2008 Jun; 48(6):939-43. PubMed ID: 18549372
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Efficacy and safety of tonabersat, a gap-junction modulator, in the acute treatment of migraine: a double-blind, parallel-group, randomized study.
    Dahlöf CG; Hauge AW; Olesen J
    Cephalalgia; 2009 Nov; 29 Suppl 2():7-16. PubMed ID: 19723121
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Migraine headaches: treatment limitations and opportunities.
    Kaniecki RG; Hutchinson S
    Postgrad Med; 2006 Apr; Spec No():14-9. PubMed ID: 17957856
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Treatment of chronic migraine with medication overuse: is drug withdrawal crucial?
    Grazzi L; Andrasik F; Usai S; Bussone G
    Neurol Sci; 2009 May; 30 Suppl 1():S85-8. PubMed ID: 19415433
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Prevalence and burden of headache and migraine in Germany.
    Radtke A; Neuhauser H
    Headache; 2009 Jan; 49(1):79-89. PubMed ID: 19125877
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Tolerability of acute migraine medications: influence of methods of assessment and relationship with headache attributes.
    Feleppa M; Apice G; D'Alessio A; Fucci S; Bigal ME
    Cephalalgia; 2008 Oct; 28(10):1012-6. PubMed ID: 18727650
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Sumatriptan for the treatment of undifferentiated primary headaches in the ED.
    Miner JR; Smith SW; Moore J; Biros M
    Am J Emerg Med; 2007 Jan; 25(1):60-4. PubMed ID: 17157685
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Meta-analysis of the efficacy and safety of zolmitriptan in the acute treatment of migraine.
    Chen LC; Ashcroft DM
    Headache; 2008 Feb; 48(2):236-47. PubMed ID: 18179569
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Chronic migraine in the population: burden, diagnosis, and satisfaction with treatment.
    Bigal ME; Serrano D; Reed M; Lipton RB
    Neurology; 2008 Aug; 71(8):559-66. PubMed ID: 18711108
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Combination therapy in acute migraine treatment: the rationale behind the current treatment options.
    Silberstein SD; Ruoff G
    Postgrad Med; 2006 Apr; Spec No():20-6. PubMed ID: 17960687
    [TBL] [Abstract][Full Text] [Related]  

  • 39. DHE in the pharmacotherapy of migraine: potential for a larger role.
    Saper JR; Silberstein S; Dodick D; Rapoport A
    Headache; 2006 Nov; 46 Suppl 4():S212-20. PubMed ID: 17078853
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Medication overuse headache.
    Lenaerts ME; Couch JR
    Minerva Med; 2007 Jun; 98(3):221-31. PubMed ID: 17592444
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.